Launch week offerEnds in00h00m00s

annual Promonthly Pro

Ethel Weld

Associate Professor of Medicine

Johns Hopkins University

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States

Articles (9)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (9)

Dan Hawcutt

Director of Research

University of Liverpool

UNITED KINGDOM

View details

Catriona Waitt

Professor

University of Liverpool

UNITED KINGDOM

View details

Kevon-Mark Jackman

Assistant Professor

Johns Hopkins University

UNITED STATES

View details

Sharon Nachman

Division chief Peds ID

Stony Brook University Renaissance School of Medicine

UNITED STATES

View details

Andrew Owen

University of Liverpool

UNITED KINGDOM

View details

Bareng Nonyane

Johns Hopkins University

UNITED STATES

View details

Kelly E. Dooley

Director, Division of Infectious Diseases & Professor and Addison B. Scoville Chair in Medicine

Johns Hopkins University School of Medicine

UNITED STATES

View details

Rachel Scott

Associate Professor

Georgetown University

UNITED STATES

View details

Adeniyi Olagunju

Reader in Perinatal Systems Pharmacology

University of Liverpool

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ethel Weld

Research Interests

Make your next move.

Explore related searches

Articles (9)

A White Paper on Advancing Long-Acting Therapeutics for Maternal and Pediatric Health by Bridging Gaps in Clinical Research, Access and Regulation

Long-Acting Antiretroviral Therapy to Treat Advanced Human Immunodeficiency Virus in Pregnancy: Let Not Delayed Detection Be the Enemy of the Good

Advancing Maternal Health with Long‐Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies

Exploring Preferences, Concerns, and Implementation of Different Long-Acting Antiretroviral Strategies for Youth with HIV Facing Adherence Challenges

Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trial

Acceptability of a rectal microbicide douche for HIV prevention: a mixed-methods analysis of a first-in-human formulation pilot study

Investigations of Long-Acting Formulations in Children, Adolescents, and Pregnant Women: A Systematic Review

Malaria in pregnancy: Modern approaches-Spotlight commmentary

Preferences and Feasibility of Long-Acting Technologies for the Treatment of Hepatitis C Virus: A Survey of Patients in Diverse Low- and Middle-Income Countries

Collaborators (9)

Dan Hawcutt

Catriona Waitt

Kevon-Mark Jackman

Sharon Nachman

Andrew Owen

Bareng Nonyane

Kelly E. Dooley

Rachel Scott

Adeniyi Olagunju

Make your next move.